Updated: 22/04/2002

Foot and Mouth Disease

 Aetiology   Epidemiology   Diagnosis   Prevention and Control   References 

AETIOLOGY

Classification of the causative agent

A virus of the family Picornaviridae, genus Aphthovirus.
Seven immunologically distinct serotypes: A, O, C, SAT1, SAT2, SAT3, Asia1

Resistance to physical and chemical action

Temperature: Preserved by refrigeration and freezing and progressively inactivated by temperatures above 50°C
pH:Inactivated by pH <6.0 or >9.0
Disinfectants: Inactivated by sodium hydroxide (2%), sodium carbonate (4%), and citric acid (0.2%). Resistant to iodophores, quaternary ammonium compounds, hypoclorite and phenol, especially in the presence of organic matter
Survival: Survives in lymph nodes and bone marrow at neutral pH, but destroyed in muscle when is pH <6.0 i.e. after rigor mortis. Can persist in contaminated fodder and the environment for up to 1 month, depending on the temperature and pH conditions


EPIDEMIOLOGY

Hosts

Transmission

Sources of virus

Occurrence

FMD is endemic in parts of Asia, Africa, the Middle East and South America (sporadic outbreaks in free areas)
For detailed information on occurrence, see recent issues of World Animal Health


DIAGNOSIS

Incubation period is 2-14 days

Clinical diagnosis

Cattle

Sheep and goats

Pigs

Lesions

Differential diagnosis

Clinically indistinguishable:

Other differential diagnosis:

Laboratory diagnosis

Procedures

Identification of the agent
  • ELISA
  • Complement fixation test
  • Virus isolation: inoculation of primary bovine thyroid cells and primary pig, calf and lamb kidney cells; inoculation of BHK-21 and IB-RS-2 cell lines; inoculation of mice
 
Serological tests
  • ELISA
  • Virus neutralisation test
(prescribed tests in the Manual)

Samples

NB!!Special precautions are required when sending perishable suspect FMD material within and between countries. See Manual, Chapter 1.4.


PREVENTION AND CONTROL

Sanitary prophylaxis

Medical prophylaxis

Inactivated virus vaccine containing an adjuvant.
Immunity: 6 months after two initial vaccinations, 1-month apart, depending on the antigenic relationship between vaccine and outbreak strains


REFERENCES AND OTHER INFORMATION

---------------------------------------------

[top]

Contact : scientific.dept@oie.int